ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; ROSIGLITAZONE M) — FDA Approval ANDA077337 (TEVA)
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; ROSIGLITAZONE M) — FDA Approval ANDA077337 (TEVA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE; Active ingredients: METFORMIN HYDROCHLORIDE; ROSIGLITAZO
| Brand name | ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE |
|---|---|
| Active ingredients | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE |
| Application number | ANDA077337 |
| Sponsor | TEVA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 5 |
| First approval date | 20140507 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →